Oxcarbazepine Tablet, Film Coated
Product Images NDC 72603-271

This description provides information on Oxcarbazepine tablets, USP. Each film-coated tablet contains 300 mg of oxcarbazepine USP. The recommended dosage can be found in the package insert. The medication should be stored in a tight container at a temperature between 20°C to 25°C, with excursions allowed to 15°C to 30°C. It emphasizes keeping the medication out of reach of children and directs pharmacists to dispense the Medication Guide to each patient separately. The manufacturer information includes Northstar Rx LLC and Annora Pharma Pt. Ltd in India. Additionally, a website and contact number are provided for accessing the Medication Guide.*

Each film-coated tablet contains 600 mg of oxcarbazepine USP. The dosage information can be found in the package insert. It is recommended to dispense in a tight container and store between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15° to 30°C (59°F to 86°F). Oxcarbazepine tablets should be kept out of reach of children. A Medication Guide is available at the provided website. The product is manufactured by Amnora Pharma Pvt. Ltd in Telangana, India. The batch coding details are listed on the packaging. Each pack contains 100 tablets.*

This is not available.*

This text seems to include data related to seizure rates in a study involving a treatment group receiving Oxcarbazepine compared to a placebo. The table might show the results of a logrank test with p-value of 0.046 and days from the first dose to the first seizure. The x-axis appears to be labeled with the number of days and the y-axis could represent the seizure rate.*

This text provides information about the exit rate and log-rank test results with a p-value of 0.0001. It also displays a time scale and a chart showing the time to exit in days for the Treatment Group {B2001, BEERA, LALAS, LRAAT, RERS, BE2E]. The text indicates two additional values "50" and "o low."*

This text provides information about an "Exit Rate" analysis using a log-rank test with a p-value of 0.0001. It also includes a chart showing the "Time to exit (Days)" for a "Treatment Group" with various data points.*